Back to Search
CHARALAMPOS SPIRIDONIDIS, MD
MD
Specialist
NPI: 1891804068Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
35050452(OH)
Research & Publications (9)
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trial.
PMID 11249055·Ann Oncol·2001
3-trial
Docetaxel and gemcitabine combinations in chemotherapy-pretreated non small-cell lung cancer.
PMID 14725738·Clin Lung Cancer·2000
8-other
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
PMID 17473660·J Thorac Oncol·2007
3-trial
Phase I study of Doxil and vinorelbine in patients with advanced malignancies.
PMID 15493354·Cancer Invest·2004
3-trial
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).
PMID 12829664·J Clin Oncol·2003
3-trial
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.
PMID 12743154·J Clin Oncol·2003
3-trial
Overlooking patient outcomes in a meta-analysis of trials of granulocyte colony-stimulating factor.
PMID 12517370·Am J Med·2002
8-other
Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial.
PMID 11697837·Ann Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8100 RAVINES EDGE CT, SUITE 100
COLUMBUS, OH 43235 - Phone
- (614) 846-0044
Quick Facts
- NPI
- 1891804068
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile